Annals of Oncology

News:

Disappointment over ABMT in breast cancer, gratification at neoadjuvant therapy in cervical cancer
Ann Oncol 10: 485.
[PDF] [Request Permissions]

Air pollution linked to lung cancer
Ann Oncol 10: 485-486.
[PDF] [Request Permissions]

Money from stamps, but not from industry
Ann Oncol 10: 486.
[PDF] [Request Permissions]

IELSG Activity expands
Ann Oncol 10: 486-487.
[PDF] [Request Permissions]

Awards, apointments
Ann Oncol 10: 487.
[PDF] [Request Permissions]

Reply to a ‘News’: Oncology in ltaly: The role of state hospitals is still predominant
Ann Oncol 10: 487-488.
[PDF] [Request Permissions]

Who wants to participate in the IELSG trials of extranodal lymphomas?
Ann Oncol 10: 488.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 10: 489-491.
[PDF] [Request Permissions]

Book reviews:

M. Ghielmini

Book review
Ann Oncol 10: 492.
[PDF] [Request Permissions]

R. Obrist

Book review
Ann Oncol 10: 592.
[PDF] [Request Permissions]

M. Fey

Book review
Ann Oncol 10: 604.
[PDF] [Request Permissions]

Editorial:

E. Reed and J. O. Armitage

Stem cell transplant at home: Glimpse of the future
Ann Oncol 10: 493-494.
[PDF] [Request Permissions]

Review:

B. Kuss and F. Cotter

Antisense - time to shoot the messenger
Ann Oncol 10: 495-503.
[PDF] [Request Permissions]

Commentary:

C. M. Wendtner, B. Schmitt, M. Wilhelm, P. Dreger, E. Montserrat, B. Emmerich, and M. Hallek

Redefining the therapeutic goals in chronic lymphocytic leukemia: Towards an evidence-based, risk-adapted therapy
Ann Oncol 10: 505-509.
[PDF] [Request Permissions]

Original articles:

A. M. Westermann, M. M. J. Holtkamp, G. A. M. Linthorst, L. van Leeuwen, E. J. M. Willemse, W. C. van Dijk, W. J. Nooijen, J. W. Baars, J. H. Schornagel, and S. Rodenhuis

At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies
Ann Oncol 10: 511-517.
[Abstract] [PDF] [Request Permissions]

A. Santoro, M. Balzarotti, C. Tondini, M. Zanini, R. Giardini, F. Latteri, I. Rampinelli, and R. Bufalino

Dose-escalation of CHOP in non-Hodgkin's lymphoma
Ann Oncol 10: 519-525.
[Abstract] [PDF] [Request Permissions]

D. Przepiorka, K. van Besien, I. Khouri, F. Hagemeister, B. Samuels, J. Folloder, N. T. Ueno, J. Molldrem, R. Mehra, M. Körbling, S. Giralt, J. Gajewski, M. Donato, K. Cleary, D. Claxton, I. Braunschweig, B. Andersson, P. Anderlini, and R. Champlin

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
Ann Oncol 10: 527-532.
[Abstract] [PDF] [Request Permissions]

M. Ghielmini, F. Zappa, A. Menafoglio, L. Caoduro, S. Pampallona, and A. Gallino

The high-dose sequential (Milan) chemotherapy/PBSC transplantation regimen for patients with lymphoma is not cardiotoxic
Ann Oncol 10: 533-537.
[PDF] [Request Permissions]

O. Pagani, C. Sessa, G. Martinelli, D. Crivellari, A. Buonadonna, B. Thürlimann, D. Hess, M. Borner, J. Bauer, G. Zampino, M. Zimatore, R. Graffeo, A. Riva, and A. Goldhirsch

Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
Ann Oncol 10: 539-545.
[Abstract] [PDF] [Request Permissions]

C. Kouroussis, E. Xydakis, A. Potamianou, T. Giannakakis, S. Kakolyris, S. Agelaki, E. Sara, N. Malamos, A. Alexopoulos, D. Mavroudis, G. Samonis, S. Papadouris, V. Georgoulias, G. Panagos, and Greek Breast Cancer Cooperative Group (GBCCG)

Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study
Ann Oncol 10: 547-552.
[Abstract] [PDF] [Request Permissions]

J.L. Misset, V. Dieras, G. Gruia, H. Bourgeois, E. Cvitkovic, S. Kalla, L. Bozec, P. Beuzeboc, C. Jasmin, J.P. Aussel, A. Riva, N. Azli, and P. Pouillart

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer
Ann Oncol 10: 553-560.
[Abstract] [PDF] [Request Permissions]

S. Fetscher, W. Brugger, R. Engelhardt, L. Kanz, J. Hasse, H. Frommhold, W. Lange, and R. Mertelsmann

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: A mature follow-up report
Ann Oncol 10: 561-567.
[Abstract] [PDF] [Request Permissions]

S. Culine, M. Fabbro, M. Ychou, G. Romieu, D. Cupissol, and H. Pujol

Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policy
Ann Oncol 10: 569-575.
[Abstract] [PDF] [Request Permissions]

N. Vey, H. Kantarjian, H. Tran, M. Beran, S. O'Brien, C. Bivins, F. Giles, J. Cortes, B. Cheson, S. Arbuck, and E. Estey

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia
Ann Oncol 10: 577-583.
[Abstract] [PDF] [Request Permissions]

Clinical case:

V. Sandor, E. Reed, G. Sarosy, L. P. Middleton, P. Davis, and E. Kohn

Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with prolonged disease-free survival
Ann Oncol 10: 585-588.
[Abstract] [PDF] [Request Permissions]

Short reports:

E. Erba, S. Ronzoni, L. Bassano, R. Giavazzi, and M. D'lncalci

The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells
Ann Oncol 10: 589-591.
[PDF] [Request Permissions]

J. Aparicio, A. Segura, S. Garcerá, A. Oltra, A. Santaballa, A. Yuste, and M. Pastor

ESHAP is an active regimen for relapsing Hodgkin's disease
Ann Oncol 10: 593-595.
[Abstract] [PDF] [Request Permissions]

N. J. Vogelzang, J. E. Herndon, II, A. Miller, G. Strauss, G. Clamon, F. M. Stewart, J. Aisner, A. Lyss, M. R. Cooper, Y. Suzuki, and M. R. Green

High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234
Ann Oncol 10: 597-600.
[Abstract] [PDF] [Request Permissions]

J. R. Rigas, M. G. Kris, V. A. Miller, K. M. W. Pisters, R. T. Heelan, S. C. Grant, D. W. Fennelly, Ting-Chao Chou, and F. M. Sirotnak

Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
Ann Oncol 10: 601-603.
[Abstract] [PDF] [Request Permissions]

S. Fetscher, W. Brugger, R. Engelhardt, L. Kanz, J. Hasse, H. Frommhold, W. Lange, and R. Mertelsmann

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: A mature follow-up report
Ann Oncol 10: 605-607.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

V. Diehl, R. Walshe, and N. Schmitz

A new approach to safeguard high standards and cost containment of stem cell transplantation in Germany
Ann Oncol 10: 609.
[PDF] [Request Permissions]

F. Roila, A. Del Favero, and E. Ballatori

Gemcitabine: A real major advance?
Ann Oncol 10: 609-610.
[PDF] [Request Permissions]

J. Médioni, M. A. Coulon, J. F. Morere, F. Hennebelle, S. Piperno-Neumann, and J. L. Breau

Anaphylaxis after oxaliplatin
Ann Oncol 10: 610.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.